Imatinib Accord 400 mg film-coated tablets clinical trials

A phase II trial of an individualized treatment strategy for patients with metastatic non-clear cell renal carcinoma

This study is testing different medicines for people with advanced kidney cancer (non-clear cell renal carcinoma) that has spread. It's looking for personalised treatments to see which ones shrink the cancer and how long they keep it under control. The goal is to find better ways to treat this type of cancer.